10-K Decoder · All companies

Arcus Biosciences, Inc.

RCUS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$247M$258M−4.3%
Operating income−$386M−$330M−17.0%
Net income−$353M−$283M−24.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$9.00M$26.0M−65.4%
Operating income−$131M−$142M+7.7%
Net income−$128M−$135M+5.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Arcus's revenue in FY2025?
$247M in FY2025 (Fiscal year ended Dec 31, 2025), −4.3% vs $258M a year earlier, per its 10-K filed Feb 2026.
Was Arcus profitable in FY2025?
No: net income was −$353M and operating income −$386M in FY2025.
What was Arcus's revenue in Q3 2026?
$9.00M (−65.4% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.